IFF is entering a strategic partnership with Salus Optima and its AI-driven personalized-nutrition technology.
IFF (New York City) has forged a strategic partnership to bring AI-driven personalized-nutrition technology to its finished-product customers. The company announced it has partnered with Salus Optima, a UK-based developer of digital tools for personalized nutrition, health, and wellness.
“By leveraging Salus Optima’s core technology with IFF’s portfolio of health-enabling ingredients from its Nourish and Health & Biosciences business divisions, brand owners can offer consumers a differentiated and engaging personalized nutrition experience that addresses the aspects that influence metabolic health,” says an IFF press release.
IFF’s work with Salus Optima will initially focus on metabolic health, including obesity, prediabetes, high cholesterol, and prehypertension. The companies will make available mobile phone technologies and wearables “to help consumers understand their unique metabolic response to food, supplements, activity, and sleep.”
The press release adds: “Key to the success of the personalized nutrition offering is blending science-backed, data-driven recommendations with behavioral change techniques, such as digital coaching, with branded products at the core of the offering.”
“The partnership with Salus Optima places us at the forefront of the personalized-nutrition space,” said Nicolas Mirzayantz, president, Nourish, IFF, in the press release.